{
  "report_rows": [
    {
      "kpi": "Net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$3.070B vs. cons $3.093B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Underlying diluted EPS",
      "prediction": "MISS",
      "answer": "pred ~$1.48 vs. cons $1.525",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Americas brand volume",
      "prediction": "IN-LINE",
      "answer": "pred ~14.05M hl vs. cons 14.168M hl",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Net sales (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~flat +/-1% CC vs. cons $11.106B; dollar comparison UNVERIFIED",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Underlying EPS (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~down 11%-15% vs. cons $4.722; dollar comparison UNVERIFIED",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Shipments vs. brand volume (H2 2026)",
      "prediction": "BETTER",
      "answer": "guide ~shipments outpace brand volume; direct consensus UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 H2 recovery scrutiny drives estimate pressure",
  "day5_confidence": "LOW"
}